ID   T34 [Human lymphoma]
AC   CVCL_J352
DR   Wikidata; Q54971521
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3261629;
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (PubMed=3261629).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 14
//
RX   PubMed=3261629;
RA   Ohno, Hitoshi
RA   Fukuhara, Shiro
RA   Arita, Yuu
RA   Doi, Shoichi
RA   Takahashi, Rei
RA   Fujii, Hiroshi
RA   Honjo, Tasuku
RA   Sugiyama, Taketoshi
RA   Uchino, Haruto
RT   "Establishment of a peripheral T-cell lymphoma cell line showing
RT   amplification of the c-myc oncogene.";
RL   Cancer Res. 48:4959-4963(1988).
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler, Hans Gunther
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//